FindTrial
Sign In

2Scores compared with a standard score in assessing patients improved symptoms post operative.

Comparing the Efficiency of validated scores to assess the improvement in quality of life in patients who underwent septoplasty.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041041
Enrollment
35
Registered
2022-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J342- Deviated nasal septum

Interventions

Intervention1: Septoplasty: Septoplasty done for the patients those who were having significant nasal obstruction and its related symptoms hampering the quality of their life. Control Intervention1: C

Sponsors

Shweta kumari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing septoplasty Symptoms persisting for over 12wks No response to the clinical treatment with topical steroid/ anti-histaminic associated with nasal decongestant. Nasal trauma causing septal deviation (chronic)

Exclusion criteria

Exclusion criteria: Sinonasal tumour Patient not fit for surgery Septoplasty done with rhinoplasty or as an entry point to other sites Septal perforation Craniofacial congenital anomalies Acute Nasal trauma/fracture Adenoid hypertrophy Patients not willing for surgery Asthma without clinical Pregnancy

Design outcomes

Primary

MeasureTime frame
Efficiency of scores in assessing the Improvement in Quality of life in patients post septoplastyTimepoint: 0,3,and 6months—

Secondary

MeasureTime frame
On which scoring patient could relate their symptoms and improvement.Timepoint: o,3 and 6 months—

Countries

India

Contacts

Public ContactShweta kumari

Tara motors hospital

Shalabh.rastogi@tatamotors.com06576695683

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026